Trial · NCT03697811
Adverse events25
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 25
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Eye pain | Eye disorders | DE-117 Ophthalmic Solution 0.002% | 2 | 107 | |
| other | Anterior chamber cell | Eye disorders | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Conjunctival oedema | Eye disorders | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Eye irritation | Eye disorders | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Eyelash hyperpigmentation | Eye disorders | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Macular oedema | Eye disorders | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Photophobia | Eye disorders | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Vision blurred | Eye disorders | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Instillation site foreign body sensation | General disorders | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Instillation site pain | General disorders | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Suture related complication | Injury, poisoning and procedural complications | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Vital dye staining cornea present | Investigations | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Bronchitis | Infections and infestations | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Influenza | Infections and infestations | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Subcutaneous abscess | Infections and infestations | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Upper respiratory tract infection | Infections and infestations | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Contusion | Injury, poisoning and procedural complications | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Muscle strain | Injury, poisoning and procedural complications | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Cyst | General disorders | DE-117 Ophthalmic Solution 0.002% | 1 | 107 | |
| other | Dizziness | Nervous system disorders | DE-117 Ophthalmic Solution 0.002% | 1 | 107 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03697811/events